Raphael Pharmaceutical (RAPH) Receivables - Other (2023)
Raphael Pharmaceutical (RAPH) posted Receivables - Other of $100000.0 for Q4 2023.
Raphael Pharmaceutical (RAPH) Receivables - Other (2023) Analysis & Trends
Raphael Pharmaceutical has reported Receivables - Other for 1 years, with the latest figure at $100000.0 in Q4 2023.
- Quarterly Receivables - Other changed N/A year-over-year to $100000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $100000.0 (changed N/A YoY) and the FY2023 annual result came in at $100000.0, changed N/A from the prior year.
- Receivables - Other held at $100000.0 in Q4 2023 per RAPH's latest filing.
- Over five years, Receivables - Other peaked at $100000.0 in Q4 2023 and troughed at $100000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |